← Every firm
STAQ Pharma, Inc. FDA Recalls
6 recalls on file across drugs, 2 of them Class I and 3 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, DeClass IIIOct 9, 2025Labeling: Incorrect or Missing Lot and/or Exp Date |
| FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nClass IIIOct 9, 2025Labeling: Incorrect or Missing Lot and/or Exp Date |
| Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42ndClass IIIOct 9, 2025Labeling: Incorrect or Missing Lot and/or Exp Date |
| ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ Pharma InClass IINov 29, 2023STAQ Pharma Inc. received consumer complaints related to lea |
| Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., DenverClass IFeb 3, 2022Labeling: Label Mix up; A limited number of syringes contain |
| HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., DenClass IFeb 3, 2022Labeling: Label Mix up; A limited number of syringes contain |